Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $9.80 and traded as high as $10.26. Cipher Pharmaceuticals shares last traded at $9.94, with a volume of 18,110 shares trading hands.
Cipher Pharmaceuticals Stock Up 4.1%
The stock has a 50 day moving average of $9.80 and a 200 day moving average of $11.33.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused primarily on developing, acquiring, and commercializing medicines for dermatology and other areas with unmet medical needs. The company’s business model emphasizes licensing and advancing differentiated prescription products rather than maintaining a broad, traditional drug-discovery operation. Cipher’s dermatology portfolio has included Epuris, an oral isotretinoin product used to treat severe acne, as well as products for conditions such as actinic keratosis and excessive facial hair.
Further Reading
- Five stocks we like better than Cipher Pharmaceuticals
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
